Explore Global Companies & Account Intelligence

Illumascape designs and develops complete innovative landscape illumination programs for residential, commercial and community properties. Continuing a family tradition in electrical contracting and after 35 years of his own experience in the business, President Paul Gross established Illumascape, Inc. in 1990 to specialize exclusively in exterior illumination designs. Using only the highest quality fixtures and in-house, skilled installers, we offer complete landscape illumination programs designed and developed for residential and commercial properties. The completed project provides security, atmosphere and investment appreciation. Additionally, we have the capabilities to install LED landscape lighting. Illumascape's sister company is Innovative Electrical Systems, which specializes in residential interior electrical (new, remodel and service), in addition to Natural Gas Generators, wireless controls and power factor / surge suppression devices.

We are an independent lighting design consultancy. Offering technical excellence and quality, creative and strategic designs, with a focus on ecological and environmental constraints. The services we offer include: Lighting Design- Interior, Exterior and Sports Lighting Street lighting design Lighting Impact Assessments Daylight, Sunlight and Overshadowing Assessments Daylight Analysis Climate Based Daylight Modelling Expert Witness Lighting controls and Electrical design Contact us: e: info@illume-design.co.uk t: 07840 054601 Website coming soon!!

Illume Learning was established by experienced and dedicated professionals in the fields of disability and education in Australia. Illume Learning provides dynamic training, engaging resources and customised consultancy services to both educators and parents. The team at Illume Learning are passionate about ensuring that students with diverse learning needs reach their potential and welcome the opportunity to work together to ensure this becomes a reality.

Illume Multimedia is a multimedia content provider based in the East San Francisco Bay area. We help businesses and organizations captivate, inform, and inspire their audience by creating visual experiences.

Comprehensive enterprise dossier available in global intelligence registry.

Illumia supply electricity, gas and energy saving services to end customers in Italy. Illumia started in 2007 and now reached a customer base of 200.000 clients (families, SME, industrial, PA). Illumia operates also in the trading market for energy and commodities in different European countries.

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.